Evidence map›Paper›PMID 39375105›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2024

[A mechanistic study of radiotherapy on intratumoral NK cell infiltration augmentation by regulating the EZH2/CXCL10 pathway in hepatocellular carcinoma cells].

X F Zhao, Q Wang, J Sun, A M Zhang, X Y Chang, W G Li, X Z Duan

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

X F ZhaoPLA Medical College, Beijing 100039, China Department of Oncology, Xi'an Daxing Hospital, Xi'an 710003.
Q WangDepartment of Radiation Oncology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
J SunDepartment of Radiation Oncology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
A M ZhangDepartment of Radiation Oncology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
X Y ChangDepartment of Radiation Oncology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
W G LiDepartment of Radiation Oncology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
X Z DuanPLA Medical College, Beijing 100039, China.

Funding

National Natural Science Foundation of China 81972856, 82003211
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularChemokine CXCL10Enhancer of Zeste Homolog 2 ProteinKiller Cells, NaturalLiver NeoplasmsAnimalsCell Line, TumorHumansMiceChemokine CXCL10CXCL10 protein, humanCxcl10 protein, mouseEnhancer of Zeste Homolog 2 ProteinEZH2 protein, human

Identifiers

PMID39375105
PMCPMC12898778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.